Stockreport

Pain Therapeutics Reports Positive Top-line Results from Nasal Abuse Potential Study with REMOXY™

PAIN THERAPEUTICS  (PTIE) 
US:NASDAQ Investor Relations: investor.paintrials.com/investor-relations
PDF - Study Meets Primary Endpoint (p- - REMOXY NDA Remains On-Track for Resubmission in Q1 2018 - AUSTIN, Texas, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, In [Read more]